Sotera Health (NASDAQ:SHC) Raised to "Strong-Buy" at Wall Street Zen

Key Points

• Research analysts at Wall Street Zen upgraded Sotera Health from a "buy" to a "strong-buy" rating, indicating increasing confidence in the company's stock.
• Sotera Health reported a quarterly earnings per share of $0.20, exceeding analysts' expectations of $0.17, alongside revenues of $294.34 million, which also surpassed projections.
• The consensus target price for Sotera Health is currently set at $16.00, reflecting analysts' positive outlook despite some mixed ratings from different firms.

Wall Street Zen upgraded shares of Sotera Health (NASDAQ:SHC - Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Saturday.

Other analysts have also issued research reports about the company. The Goldman Sachs Group upgraded Sotera Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $14.00 to $17.00 in a report on Monday, May 5th. Barclays reiterated an "overweight" rating on shares of Sotera Health in a report on Friday, August 8th. Finally, Piper Sandler dropped their price objective on Sotera Health from $15.00 to $13.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 23rd. Four research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $16.00.

Sotera Health Stock Up 0.9%

SHC traded up $0.14 on Friday, hitting $16.30. 1,413,709 shares of the company were exchanged, compared to its average volume of 1,677,774. Sotera Health has a 12 month low of $9.53 and a 12 month high of $17.08. The company has a market cap of $4.63 billion, a PE ratio of 203.78 and a beta of 1.81. The company has a debt-to-equity ratio of 4.49, a quick ratio of 2.23 and a current ratio of 2.47. The stock's fifty day moving average is $12.16 and its 200-day moving average is $12.14.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its earnings results on Friday, August 8th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.03. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.The business had revenue of $294.34 million for the quarter, compared to analyst estimates of $275.81 million. During the same quarter in the prior year, the company posted $0.19 earnings per share. Sotera Health's revenue was up 6.4% on a year-over-year basis. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. Equities research analysts predict that Sotera Health will post 0.61 EPS for the current fiscal year.

Institutional Trading of Sotera Health

Several institutional investors and hedge funds have recently bought and sold shares of the business. Quarry LP acquired a new stake in Sotera Health during the 4th quarter worth approximately $28,000. UMB Bank n.a. lifted its holdings in Sotera Health by 112.8% during the 2nd quarter. UMB Bank n.a. now owns 2,635 shares of the company's stock worth $29,000 after purchasing an additional 1,397 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in Sotera Health by 3,690.1% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,691 shares of the company's stock worth $31,000 after purchasing an additional 2,620 shares during the last quarter. Parallel Advisors LLC lifted its holdings in Sotera Health by 124.0% during the 2nd quarter. Parallel Advisors LLC now owns 3,340 shares of the company's stock worth $37,000 after purchasing an additional 1,849 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its holdings in Sotera Health by 831.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company's stock worth $37,000 after purchasing an additional 2,935 shares during the last quarter. Institutional investors own 91.03% of the company's stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.